CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Numerion Labs
Numerion Labs logo

Numerion Labs

Artificial intelligence for drug discovery.

San Francisco, CA, US🇺🇸
Accelerator
Y Combinator logoY CombinatorW15
Overview
Compare
Fundraising
Employees
Library

Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms.

The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.

Numerion Labs - Similar Companies

Isomorphic Labs logo

Isomorphic Labs

Atommap logo

Atommap

PostEra logo

PostEra

postera.ai

Cognaisent logo

Cognaisent

cognaisent.com

Proxima logo

Proxima

proximabio.com

Verge Genomics logo

Verge Genomics

vergegenomics.com

Iambic Therapeutics logo

Iambic Therapeutics

iambic.ai

Diffuse Bio logo

Diffuse Bio

diffuse.bio

Superluminal Medicines logo

Superluminal Medicines

superluminalrx.com

DeepCure logo

DeepCure

deepcure.ai

TandemAI logo

TandemAI

tandemai.com

Valence Discovery logo

Valence Discovery

valencelabs.com

Kimia Therapeutics logo

Kimia Therapeutics

kimiatx.com

Biosim logo

Biosim

Synfini logo

Synfini

synfini.com

Numerion Labs - Quick Facts

Who are Numerion Labs' competitors?

Companies similar to Numerion Labs include Isomorphic Labs, Atommap, PostEra and Cognaisent.

Where is Numerion Labs' headquarters located?

Numerion Labs' headquarters is located in San Francisco, CA, US.

When was Numerion Labs' last funding round?

Numerion Labs' most recent funding round was for $120k (USD) in January 2015.

How much disclosed funding has Numerion Labs raised?

As of Jan 1, 2015, Numerion Labs has disclosed funding of $120k (USD). Undisclosed round amounts are excluded.

How many employees does Numerion Labs have?

Numerion Labs has 67 employees as of Oct 13, 2023.

Numerion Labs - Classification

Ownership
  • Venture-backed
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech